Ark Clinical Research
2600 Redondo Ave. Suite 400
Long Beach, CA 90806
Currently Enrolling Trials
Ark Clinical Research is a multitherapeutic clinical research site located in Long Beach, Calif., specializing in late-phase outpatient clinical trials in asthma, allergy, respiratory, immunology, internal medicine and dermatology in service to the pharmaceutical, biotechnology and medical device industries. Our mission is to translate medical research into therapies that benefit patients. By navigating integrated research solutions through people, systems and providers, we are able to bring innovative therapies, treatments, devices and delivery methods to market, with the well-being of patients as our top priority.
As a clinical research site and medical research organization, our core values are what drive our business and the goals we work towards. Ark Clinical Research’s core values are:
Ark strives to empower patients to achieve optimal and holistic health goals for higher quality of life.
Ark’s mission is to be a center of excellence for bridging innovative research to current medical therapies utilizing our expertise, teamwork and compassion for our patients.
We at Ark believe in…
Highest quality of patient care: With patient safety first, we at Ark combine standard modes of care with new research therapies that will benefit patients’ overall health outcome.
Excellence in data integrity: Exercising both good clinical and documentation practices, Ark believes in doing it right the first time to ensure high-quality data for the advancement of research and our reliability as an organization.
Client partnership/trust: We believe that excellence in research is the result of promoting a cooperative, transparent, communicative environment that builds trust and confidence, not only for our clients but also for patients through the example of collaboration.
Teamwork: A team excels through building and refining one another, bringing out the best that we can in each other, while understanding the visions of the individual and organization. The compilation of expertise, compassion and willingness to learn builds a strong foundation that is worthwhile.
Balance: We believe in promoting a balanced lifestyle between work and family for our team here at Ark to create an atmosphere that is always refreshed and ready to deliver excellence in patient care research.
With these core values at the forefront of everything it does, Ark Clinical Research promises to be your go-to development partner for late-phase outpatient clinical trials.
Ark Clinical Research has over 50 years of cumulative experience in conducting clinical trials over an array of therapeutic areas. We specialize in late phase outpatient research for the following indications:
- Allergy/Asthma in Adults/Pediatrics
- Vaccine/Challenge Studies
- Women's Health
- Gastrointestinal Disorders
- Family Medicine
- Healthy Volunteers
- Internal Medicine
- Obstetrics/Gynecology (Women’s Health)
Our site is centrally located in the heart of Long Beach, Calif., less than two miles from major medical centers and the airport. Ark Clinical Research is an extension of a private allergy and asthma practice. We specialize in those therapeutic areas for both adults and children. The site has all the equipment needed for skin tests, immunotherapy, pulmonary function assessments, breathing treatments, etc. We offer free transportation for special circumstances.
Kenneth Kim, MD (PI)
Dr. Kenneth Kim, a summa cum laude graduate of Harvard College, received his MD from Harvard Medical School. Following a fellowship at the MIT Sloan School of Management, he completed his internal medicine and allergy/immunology training at UCLA. Dr. Kim has served as a medical monitor, consultant and investigator on more than 700 clinical trials and has published more than 40 research articles and 50 abstracts in peer-reviewed journals. He has presented to the FDA on challenges and strategies of dose selection and study design for pediatric trials and has met key decisionmakers at the PMDA, SFDA and KFDA. He has spoken at multiple national and international meetings and is a well-recognized expert in the areas of clinical pharmacology, ethnobridging, and respiratory and allergic diseases.
Betty Liu, MD (Sub-I)
Dr. Betty Liu is a Southern California native who attended the University of California, Berkeley, for her undergraduate work. She graduated with honors in molecular and cell biology and public policy. She attended the University of California, San Diego, for medical school with her clinical training focused in pediatrics. She completed her pediatric training at Harbor-UCLA Medical Center and her allergy/immunology training at the University of Iowa Hospital and Clinics. Dr. Liu is both a board-certified pediatrician and allergist/immunologist.
Though she cares for patients of all ages, Dr. Liu has a special interest in asthma and food allergies in children. She takes pride in working closely together with her patients to develop a treatment plan that is best for them. Dr. Liu also acts as a supporting investigator in clinical trials for asthma and allergic rhinitis.
George Huthsteiner MD, FACCP (Sub-I)
Dr. George Huthsteiner has more than 35 years of experience practicing both internal medicine and pulmonary disease. He received his medical degree from the University of California San Diego School of Medicine. Dr. Huthsteiner is a truly compassionate physician who maintains a positive rapport with both patients and sponsors.
Ellen Garibaldi, M.D. (Sub-I)
Dr. Garibaldi is a recent arrival to Southern California from Pennsylvania. She attended the University of Pennsylvania for her undergraduate studies and graduated cum laude from the Department of Psychology Honors Research Program. She attended the Medical College of Pennsylvania and was awarded the Clinical Pediatrics Prize at graduation. She pursued pediatrics training at the children's hospital of Temple University Medical Center and went on to a year of training at Thomas Jefferson University Medical Center's residential hospital for severe asthma.
Ark Clinical Research has the capabilities to utilize both central or local IRBs.